title: Targeted Therapies in Older Adults With Breast Cancer: What Do We Know?
authors.affiliation: University of North Carolina, Chapel Hill, NC; and Rambam Health Care Campus, Haifa, Israel.
authors.forename: Shlomit
authors.initials: S
authors.lastname: Strulov Shachar
authors.affiliation: City of Hope Comprehensive Cancer Center, Duarte, CA.
authors.forename: Arti
authors.initials: A
authors.lastname: Hurria
authors.affiliation: University of North Carolina, Chapel Hill, NC muss@med.unc.edu.
authors.forename: Hyman B
authors.initials: HB
authors.lastname: Muss
mesh_terms: D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002986:Clinical Trials as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000009:adverse effects / Q000379:methods*; D018579:Patient Selection; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents